The Effect of Teleyoga in Liver Transplant Patients

May 4, 2026 updated by: Bilge Summakoğlu, Dokuz Eylul University

The Effect of Teleyoga on Balance, Frailty, Cognition and Quality of Life in Liver Transplant Patients

Online yoga practices will be applied in liver transplant patients and the effects of online yoga on balance, frailty, cognition and quality of life of transplant patients will be examined.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study will include liver transplant patients who applied to Dokuz Eylül University Faculty of Medicine, Department of Surgical Medical Sciences, Department of General Surgery Outpatient Clinic. The aim of the study is to investigate the effect of online yoga practice on balance, frailty, cognition and quality of life levels in liver transplant patients. The study will include 26 patients with liver transplantation who meet the criteria. Participants will first be informed about the study and individuals will be included in the study after signing the informed consent form. Demographic information of liver transplant patients will be obtained and their balance, frailty, cognition and quality of life levels and post-transplant symptoms (symptoms seen in people) will be evaluated.

Online yoga practices will be applied to liver transplant patients for 8 weeks, 2 days a week, 30 minutes a day. Online yoga (teleyoga) will be performed via video call with people who meet the inclusion criteria. After 8 weeks of yoga intervention, balance, frailty, cognition and quality of life levels and post-transplant symptoms will be re-evaluated.

Balance measurements will be evaluated with Biodex Balance System (BSS). Frailty levels will be assessed by Short Physical Performance Battery and FRAIL frailty questionnaire. Cognition will be assessed by trail making test and stroop test. Quality of life will be evaluated with Short Form-36 quality of life scale and post-transplantation symptoms will be evaluated with Modified Post-Transplantation Symptom Occurrence and Discomfort Status-58-Item Scale-Turkey.

The evaluations are planned to last 1-2 hours.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • İzmir
      • Izmir, İzmir, Turkey (Türkiye), 35160
        • Dokuz Eylul University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being between the ages of 18-65
  • Liver transplantation at least 6 months ago
  • Individuals with a Mini Mental Test score greater than 24

Exclusion Criteria:

  • Pregnancy
  • Central Nervous System Dysfunction
  • Musculoskeletal deformity
  • Vestibular dysfunction
  • Specific neurological pathology (Parkinson's, stroke, epilepsy)
  • Those with severe systemic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: treatment group
The only group in the study was liver transplant patients who practised yoga online.
Other: yoga (online)
8-week online yoga practices, 2 days a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biodex Balance System
Time Frame: two weeks
Balance will be assessed separately with the Biodex Balance System (Biodex Medical Systems, Inc., Shirley, NY) standing, eyes open, static and dynamic. For static and dynamic balance assessments, each test will be performed for 20 seconds with 3 repetitions. Average scores will be recorded after the evaluation. An increase in scores indicates worsening of balance and a decrease in scores indicates improvement in balance.
two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FRAIL frailty scale
Time Frame: two weeks
In the FRAIL frailty scale; patients' weight loss, fatigue, slowness, decreased physical activity and weakness are examined. Those with 0 points from this questionnaire are classified as fit, those with 1-2 points are classified as pre-frail, and those with 3 or more points are classified as frail.
two weeks
Short Physical Performance Battery
Time Frame: two weeks
And The Short Physical Performance Battery consists of 3 objective tests assessing lower body function. All three physical performance measures (walking speed, balance, getting up from a chair) are scored between 0-4 according to the duration of the activity, and the scores of the three tests are summed to obtain a total score between 0 ( bad) and 12 (very good).
two weeks
The stroop test
Time Frame: two weeks
The Stroop test . On each card, there are 6 lines consisting of 4 items. These stimulus cards constitute the parts of the test and the tasks that the participant has to fulfil against these stimulus cards constitute the parts of the test.
two weeks
the tracking test
Time Frame: two weeks
There are two parts in the test, A and B. The completion time of the sequential patterns in the sections is analysed. Eight sub-scores are calculated by looking at the time, number of errors and corrections.
two weeks
Modified Transplantation Symptom Occurrence and Discomfort - 58-Item Scale
Time Frame: two weeks
Each item of the scale assesses a side effect of immunosuppressive drugs. The form assesses the frequency or intensity of symptom occurrence and the discomfort caused by the symptom in the presence of the symptom. People will be asked to tick '0' if they have not experienced any symptoms in the last 4 weeks, '1' if they have rarely, '2' if they have sometimes, '3' if they usually, or '4' if they have experienced a lot of symptoms. Afterwards, according to the distress caused by the symptom, the respondent will be asked to mark the situation he/she experienced from 0 (no distress at all) to 4 (extreme distress).
two weeks
short form-36 quality of life scale
Time Frame: two weeks
It was evaluated with Short form-36 quality of life scale. It evaluates quality of life especially in individuals with physical illness and provides measurement of quality of life in 8 dimensions: physical function (10 items), social function (2 items), role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), vitality (4 items), pain (2 items) and general perception of health (5 items). A total score is given separately for each subscale and scores range from 0-100. A score of '100' indicates good health status, while a score of '0' indicates poor health status.
two weeks
Beck depression scale
Time Frame: two weeks
Depression assessment with Beck depression scale. The scale consists of 21 items. Each item is scored between 0-3. A higher total score indicates a higher severity or level of depression.
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Dokuz Eylul University

Investigators

  • Study Chair: bilge summakoğlu, Dokuz Eylul University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2023

Primary Completion (Actual)

June 10, 2024

Study Completion (Actual)

September 16, 2024

Study Registration Dates

First Submitted

August 19, 2024

First Submitted That Met QC Criteria

August 19, 2024

First Posted (Actual)

August 21, 2024

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 4, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DEU-SBF-BS-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Transplant Disorder

Clinical Trials on yoga (online)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe